Overview

Post-menopausal Women Osteoporosis(Phase III)

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and the safety of Risedronate, cholecalciferol combination tablet in patients with Osteoporosis
Phase:
Phase 3
Details
Lead Sponsor:
Hanlim Pharm. Co., Ltd.
Treatments:
Cholecalciferol
Etidronic Acid
Risedronate Sodium
Risedronic Acid